Supplemental material
Human Vaccines & Immunotherapeutics
Volume 18, 2022 - Issue 1
Pneumococcal – Research Paper
Impact of pneumococcal conjugate vaccines on healthcare utilization and direct costs for otitis media in children ≤2 years of age in two Swedish regions
Mark Edmondson-Jonesa Parexel International, Stockholm, Sweden
https://orcid.org/0000-0003-1113-8008View further author information
https://orcid.org/0000-0003-1113-8008View further author information, Therese Dibberna Parexel International, Stockholm, Swedenhttps://orcid.org/0000-0003-0645-1550View further author information
https://orcid.org/0000-0003-0645-1550View further author information, Marcus Hultberga Parexel International, Stockholm, Swedenhttps://orcid.org/0000-0003-0541-0538View further author information
https://orcid.org/0000-0003-0541-0538View further author information, Bengt Anella Parexel International, Stockholm, Swedenhttps://orcid.org/0000-0002-3822-7628View further author information
https://orcid.org/0000-0002-3822-7628View further author information, Emma Medina Parexel International, Stockholm, Swedenhttps://orcid.org/0000-0002-7327-7954View further author information
https://orcid.org/0000-0002-7327-7954View further author information, Yang Fengb GSK, Wavre, Belgiumhttps://orcid.org/0000-0003-4470-6411View further author information
https://orcid.org/0000-0003-4470-6411View further author information & Carla Talaricoc GSK, Rockville, MD, USACorrespondence[email protected]
https://orcid.org/0000-0001-9107-5873View further author information
https://orcid.org/0000-0001-9107-5873View further author information show all